ATE491689T1 - Heteroaryl diazacycloalkane als cholinergische ligande für nikotin-acetylcholin-rezeptoren - Google Patents

Heteroaryl diazacycloalkane als cholinergische ligande für nikotin-acetylcholin-rezeptoren

Info

Publication number: ATE491689T1
Authority: AT; Austria
Prior art keywords: alkyl; alkoxy; cycloalkylalkyl; cycloalkyl; alkynoxy
Prior art date: 1997-10-27

Application number

AT04102866T

Other languages

English (en)

Inventor

Dan Peters

Gunnar Olsen

Simon Nielsen

Elsebet Nielsen

Original Assignee

Neurosearch As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-27

Filing date

1998-10-27

Publication date

2011-01-15

1998-10-27 Application filed by Neurosearch As filed Critical Neurosearch As

2011-01-15 Application granted granted Critical

2011-01-15 Publication of ATE491689T1 publication Critical patent/ATE491689T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/22—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing two or more pyridine rings directly linked together, e.g. bipyridyl
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Psychology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Addiction (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT04102866T 1997-10-27 1998-10-27 Heteroaryl diazacycloalkane als cholinergische ligande für nikotin-acetylcholin-rezeptoren ATE491689T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DK122597		1997-10-27
DK40998		1998-03-24
DK79698		1998-06-19

Publications (1)

Publication Number	Publication Date
ATE491689T1 true ATE491689T1 (de)	2011-01-15

Family

ID=27220661

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT98951286T ATE278670T1 (de)	1997-10-27	1998-10-27	Heteroaryl diazacycloalkane als cholinergische ligande für nikotin-acetylcholin-rezeptoren
AT04102866T ATE491689T1 (de)	1997-10-27	1998-10-27	Heteroaryl diazacycloalkane als cholinergische ligande für nikotin-acetylcholin-rezeptoren

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT98951286T ATE278670T1 (de)	1997-10-27	1998-10-27	Heteroaryl diazacycloalkane als cholinergische ligande für nikotin-acetylcholin-rezeptoren

Country Status (25)

Country	Link
US (2)	US6825189B1 (de)
EP (2)	EP1027336B1 (de)
JP (1)	JP4570773B2 (de)
KR (1)	KR100607838B1 (de)
CN (1)	CN1131211C (de)
AT (2)	ATE278670T1 (de)
AU (1)	AU744539B2 (de)
BR (1)	BR9813279B1 (de)
CA (1)	CA2306093C (de)
CZ (1)	CZ299499B6 (de)
DE (2)	DE69826883T2 (de)
DK (1)	DK1027336T3 (de)
EE (1)	EE04588B1 (de)
ES (1)	ES2230723T3 (de)
HU (1)	HU226859B1 (de)
IL (2)	IL135108A0 (de)
IS (1)	IS5420A (de)
NO (1)	NO317094B1 (de)
NZ (1)	NZ503520A (de)
PL (1)	PL203140B1 (de)
PT (1)	PT1027336E (de)
RU (1)	RU2205179C2 (de)
SK (1)	SK285198B6 (de)
TR (1)	TR200001171T2 (de)
WO (1)	WO1999021834A1 (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7214686B2 (en)	1997-06-30	2007-05-08	Targacept, Inc.	Pharmaceutical compositions and methods for effecting dopamine release
SK285198B6 (sk) *	1997-10-27	2006-08-03	Neurosearch A/S	Homopiperazínový derivát, farmaceutická kompozícia obsahujúca tento derivát a jeho použitie
NZ514021A (en) *	1999-04-26	2001-09-28	Neurosearch As	Heteroaryl diazacycloalkanes, their preparation and use
EP1177196B1 (de) *	1999-05-04	2004-03-10	Neurosearch A/S	Heteroaryl diazabicycloalkene, deren herstellung und verwendung
GB9914026D0 (en) *	1999-06-17	1999-08-18	Zeneca Ltd	Chemical compounds
AU1996301A (en) *	1999-12-14	2001-06-25	Neurosearch A/S	Novel heteroaryl-diazabicycloalkanes
US6809105B2 (en)	2000-04-27	2004-10-26	Abbott Laboratories	Diazabicyclic central nervous system active agents
MY137020A (en) *	2000-04-27	2008-12-31	Abbott Lab	Diazabicyclic central nervous system active agents
ES2269467T3 (es)	2000-10-13	2007-04-01	Neurosearch A/S	Tratamiento de transtornos afectivos por la accion combinada de un agonista del receptor nicotinico y una sustancia monoaminergenica.
CA2341952A1 (en)	2001-03-23	2002-09-23	Universite Laval	Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases
US8039459B2 (en)	2004-07-15	2011-10-18	Universite Laval	Nicotinic receptor agonists for the treatment of inflammatory diseases
US8557804B2 (en)	2002-03-25	2013-10-15	Universite Laval	Nicotinic receptor agonists for the treatment of inflammatory diseases
BR0312414A (pt)	2002-07-05	2005-05-10	Targacept Inc	Compostos de n-aril diazaespirociclico e métodos para a preparação e uso dos mesmos
AU2003254016A1 (en)	2002-07-19	2004-02-09	Catholic Healthcare West	Methods and compositions relating to chimeric nicotinic receptor subunits
US7098331B2 (en)	2003-03-05	2006-08-29	Targacept, Inc.	Arylvinylazacycloalkane compounds and methods of preparation and use thereof
GB0316915D0 (en)	2003-07-18	2003-08-20	Glaxo Group Ltd	Compounds
DE602004024565D1 (de)	2003-10-15	2010-01-21	Targacept Inc	Azabicyclische verbindungen zur linderung von schmerzen und zur behandlung von erkrankungen des zentralen nervensystems
EP1802258A4 (de)	2004-09-13	2015-09-23	Chrono Therapeutics Inc	Biosynchrone transdermale arzneiabgabe
AU2005286793A1 (en)	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes
CN101044134A (zh)	2004-09-20	2007-09-26	塔加西普特公司	具有烟碱性胆碱能受体活性的氮杂螺烯和氮杂螺烷化合物
JP4958787B2 (ja) *	2004-09-20	2012-06-20	ゼノン・ファーマシューティカルズ・インコーポレイテッド	ヒトステアロイル−ＣｏＡデサチュラーゼを阻害するためのピリジン誘導体
US7767677B2 (en)	2004-09-20	2010-08-03	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
CA2580857A1 (en)	2004-09-20	2006-09-28	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
CA2580762A1 (en)	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as therapeutic agents
US8071603B2 (en)	2004-09-20	2011-12-06	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
AU2005286728A1 (en)	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
EP1814551A2 (de)	2004-09-20	2007-08-08	Xenon Pharmaceuticals Inc.	Pyridazin-derivate zur verhinderung menschlicher stearoyl-coa-desaturase
US7459469B2 (en)	2004-11-10	2008-12-02	Targacept, Inc.	Hydroxybenzoate salts of metanicotine compounds
UA88792C2 (ru)	2004-11-10	2009-11-25	Таргасепт, Інк.	Гидроксибензоатные соли метаникотиновых соединений
MX2007008279A (es) *	2005-01-25	2008-02-15	Epix Delaware Inc	Compuestos de arilamina sustituidos y su uso como moduladores de la 5-ht6.
FR2885615B1 (fr) *	2005-05-12	2007-06-22	Servier Lab	Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2885616B1 (fr)	2005-05-12	2007-06-22	Servier Lab	Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MX2007015216A (es)	2005-06-03	2008-02-22	Xenon Pharmaceuticals Inc	Derivados de aminotiazol y sus usos como agentes terapeuticos.
FR2889188B1 (fr) *	2005-07-28	2007-09-07	Servier Lab	Nouveaux composes 1,1-pyridinylaminocyclopropanamines polysubstitues, leur procede de preparation et les compositions phamaceutiques qui les contiennent
CA2618700A1 (en)	2005-08-22	2007-03-01	Targacept, Inc.	Heteroaryl-substituted diazatricycloalkanes, methods for its preparation and use thereof
US20070134169A1 (en) *	2005-12-11	2007-06-14	Rabinoff Michael D	Methods for smoking cessation or alcohol cessation or other addiction cessation
EP2133338A1 (de)	2006-05-09	2009-12-16	AstraZeneca AB	Salzformen von (2S)-(4E)-N-Methyl-5-[(5-Isopropoxy)pyridin-3-yl]-4-Penten-2-Amin
TWI389889B (zh)	2006-05-09	2013-03-21	Targacept Inc	（２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型
US7902184B2 (en)	2006-05-30	2011-03-08	Hoffmann-La Roche Inc.	Piperazinyl pyrimidine derivatives
EP2255848A3 (de)	2006-09-04	2011-04-06	NeuroSearch AS	Pharmazeutische Kombinationen von Nicotin Rezeptor Modulatoren und Agenzien zur Verbesserung der kognitiven Fähigkeiten
ES2521494T3 (es)	2007-04-02	2014-11-12	Parkinson's Institute	Métodos y composiciones para la reducción de los efectos secundarios de tratamientos terapéuticos
EP2155689B1 (de)	2007-05-31	2015-07-08	Boehringer Ingelheim International GmbH	Ccr2-rezeptorantagonisten und anwendungen davon
EP2217597B1 (de)	2007-10-01	2011-03-30	Comentis, Inc.	1h-indol-3-carbonsäure-chinuclidin-4-ylmethylesterderivate als liganden für den nikotinischen alpha-7-acetylcholinrezeptor zur behandlung von alzheimer-krankheit
US8697722B2 (en) *	2007-11-02	2014-04-15	Sri International	Nicotinic acetylcholine receptor modulators
EP2379525B1 (de)	2008-12-19	2015-07-29	Boehringer Ingelheim International GmbH	Cyclische pyrimidin-4-carbonsäureamide als antagonisten des ccr2-rezeptors zur behandlung von entzündungen, asthma und copd
EP2509982A1 (de)	2009-12-07	2012-10-17	Targacept, Inc.	3,6-diazabicyclo[3.1.1]heptane als neuronale nikotinische acetylcholinreceptorliganden
PE20121614A1 (es)	2009-12-17	2012-12-21	Boehringer Ingelheim Int	Derivados de 6-amino,4-carbonil-pirimidina sustituida como antagonistas del receptor ccr2
CA2787063C (en) *	2010-01-11	2018-11-27	Astraea Therapeutics, Llc	Nicotinic acetylcholine receptor modulators
ES2667049T3 (es) *	2010-02-05	2018-05-09	Merck Patent Gmbh	Derivados de heteroaril-[1,8]naftiridina
US20110256064A1 (en) *	2010-04-16	2011-10-20	Ac Immune, S.A.	Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins
WO2011141477A1 (en)	2010-05-12	2011-11-17	Boehringer Ingelheim International Gmbh	New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
JP2013526507A (ja)	2010-05-12	2013-06-24	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	新規ｃｃｒ２受容体アンタゴニスト、その製造方法及び薬物としてのその使用
JP5647339B2 (ja)	2010-05-17	2014-12-24	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｃｃｒ２アンタゴニスト及びこれらの使用
WO2011146009A1 (en)	2010-05-20	2011-11-24	Targacept Inc.	New process for the preparation of aryl substituted olefinic amines
JP5636094B2 (ja)	2010-05-25	2014-12-03	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｃｃｒ２受容体アンタゴニスト
WO2011151251A1 (en)	2010-06-01	2011-12-08	Boehringer Ingelheim International Gmbh	New ccr2 antagonists
US8920793B2 (en) *	2011-02-01	2014-12-30	Industrial Cooperation Foundation Chonbuk National University	Biodegradable PAOX polymer particle with cationic property
WO2013010839A1 (en)	2011-07-15	2013-01-24	Boehringer Ingelheim International Gmbh	Novel and selective ccr2 antagonists
CN102924390B (zh) *	2012-09-07	2014-12-31	苏州康润医药有限公司	1,5-二氮杂环辛烷-1-甲酸叔丁酯的合成方法
US9434724B2 (en)	2014-07-11	2016-09-06	Alpharmagen, Llc	Quinuclidines for modulating alpha 7 activity
US10213586B2 (en)	2015-01-28	2019-02-26	Chrono Therapeutics Inc.	Drug delivery methods and systems
CN108026087B (zh)	2015-07-02	2021-06-04	中枢疗法公司	氨基嘧啶甲酮衍生物的柠檬酸盐
WO2018129304A1 (en)	2017-01-06	2018-07-12	Chrono Therapeutics Inc.	Transdermal drug delivery devices and methods
WO2019232077A1 (en)	2018-05-29	2019-12-05	Chrono Therapeutics Inc.	Drug delivery methods and systems
CA3119992A1 (en)	2018-11-16	2020-05-22	Morningside Venture Investments Limited	Thermally regulated transdermal drug delivery system

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2985657A (en) *	1959-10-12	1961-05-23	Paul A J Janssen	1-(aroylalkyl)-4-heterocyclylpiperazines
JPS4966691A (de) *	1972-10-30	1974-06-27
US4017622A (en)	1972-12-18	1977-04-12	Dainippon Pharmaceutical Co., Ltd.	Piperazine derivatives
AT330777B (de)	1973-09-08	1976-07-26	Thomae Gmbh Dr K	Verfahren zur herstellung von neuen isochinolinderivaten und deren salzen
SE421695B (sv) *	1975-04-21	1982-01-25	Merck & Co Inc	Sett att framstella piperazinylpyraziner
US3994898A (en) *	1975-10-16	1976-11-30	E. R. Squibb & Sons, Inc.	1,2,4-Triazolo (4,3-b) pyridazin-3-ones
NL171985C (nl) *	1976-02-10	1983-06-16	Rhone Poulenc Ind	Werkwijze voor het bereiden van preparaten met werking tegen schistosomiasis, de aldus verkregen gevormde preparaten en werkwijze voor het bereiden van 1,2-dithioolverbindingen.
GB1542030A (en) *	1976-08-19	1979-03-14	Sterling Drug Inc	Cyclic alkylidenyl n-(pyridazinyl)aminomethylenemalomates and their preparation
DE2708187A1 (de) *	1977-02-25	1978-08-31	Thomae Gmbh Dr K	Neue pyrido-pyridazin-one
HU176972B (hu) *	1977-06-13	1981-06-28	Gyogyszerkutato Intezet	Sposob poluchenija novykh proizvodnykh piridazinil-gidrazona
US4163849A (en) *	1978-03-17	1979-08-07	Merck & Co., Inc.	Piperazinylpyrazines
US4179563A (en) *	1978-05-19	1979-12-18	Warner-Lambert Company	3-Aryloxy-substituted-aminopyridines and methods for their production
JPS5618983A (en) *	1979-07-25	1981-02-23	Eisai Co Ltd	Theophylline derivative and its preapration
US4251530A (en)	1980-02-19	1981-02-17	Merck & Co., Inc.	2-{[4-(6-Substituted-2-pyrazinyl)-1-piperazinyl]alkyl}-5-substituted-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one analgesic agents
DE3034001A1 (de) *	1980-09-10	1982-04-22	Hoechst Ag, 6000 Frankfurt	Isochinolinderivate, verfahren zu ihrer hersellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung
FI70411C (fi) *	1980-12-29	1986-09-19	Pfizer	Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat
US5001125A (en) *	1984-03-26	1991-03-19	Janssen Pharmaceutica N.V.	Anti-virally active pyridazinamines
ZA852235B (en) *	1984-03-26	1986-11-26	Janssen Pharmaceutica Nv	Anti-virally active pyridazinamines
ES8802151A1 (es) *	1985-07-31	1988-04-01	Janssen Pharmaceutica Nv	Un procedimiento para la preparacion de nuevos piridazinaminas.
GB8603120D0 (en) *	1986-02-07	1986-03-12	Pfizer Ltd	Anti-dysrhythmia agents
GB8609630D0 (en)	1986-04-19	1986-05-21	Pfizer Ltd	Anti-arrhythmia agents
SE8701375D0 (sv)	1987-04-02	1987-04-02	Leo Ab	Novel pyridyl- and pyrimidyl derivatives
MY104343A (en) *	1987-11-23	1994-03-31	Janssen Pharmaceutica Nv	Novel pyridizinamine deravatives
US4876256A (en)	1988-04-29	1989-10-24	Merck & Co., Inc.	Alkylpiperazinylpyridines as hypoglycemic agents
SE8803429D0 (sv)	1988-09-28	1988-09-28	Pharmacia Ab	Novel pyridyl- and pyrimidyl derivatives
US5019574A (en) *	1988-09-30	1991-05-28	Chugai Seiyaku Kabushiki Kaisha	3,4-diaminoquinoline and 3,4-diamino-5,6,7,8-tetrahydroquinoline compounds useful for improving psychoneural function
JPH02167265A (ja) *	1988-09-30	1990-06-27	Chugai Pharmaceut Co Ltd	新規な３，４―ジアミノキノリン及びピリジン系化合物
EP0370560B1 (de)	1988-11-24	1994-01-12	Akzo Nobel N.V.	1-[Mono- oder bis(trifluormethyl)-2-pyridinyl]piperazine enthaltende pharmazeutische Zusammensetzungen
US4994456A (en) *	1989-03-01	1991-02-19	Nisshin Flour Milling Co., Ltd.	Pyridinecarboxylic acid amide derivatives and pharmaceutical compositions comprising same
JP2843632B2 (ja) *	1989-03-01	1999-01-06	日清製粉株式会社	ピリジンカルボン酸アミド誘導体
NZ233526A (en) *	1989-05-15	1991-09-25	Janssen Pharmaceutica Nv	Pyridazine derivatives and their pharmaceutical compositions
HUT61296A (en) *	1989-12-28	1992-12-28	Upjohn Co	Process for producing substituted diaromatic compounds against aids and pharmaceutical compositions comprising same
DE69217224T2 (de) *	1991-07-03	1997-06-05	Pharmacia & Upjohn Co., Kalamazoo, Mich.	Substituierte indole als anti-aids pharmaceutische zubereitungen
JPH05345764A (ja) *	1991-11-26	1993-12-27	Asahi Chem Ind Co Ltd	新規アゼピン誘導体、その製造法およびその用途
SE9201239D0 (sv)	1992-04-21	1992-04-21	Kabi Pharmacia Ab	Agents for treating substance abuse disorders
TW279864B (de) *	1993-02-19	1996-07-01	Janssen Pharmaceutica Nv
JPH08507788A (ja)	1993-03-17	1996-08-20	アボツト・ラボラトリーズ	置換脂環式アミン含有大環状免疫調節剤
GB9408185D0 (en) *	1994-04-25	1994-06-15	Fujisawa Pharmaceutical Co	New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
US5607936A (en) *	1994-09-30	1997-03-04	Merck & Co., Inc.	Substituted aryl piperazines as neurokinin antagonists
AU4420296A (en)	1994-11-23	1996-06-17	Neurogen Corporation	Aminomethyl aryl compounds; dopamine receptor subtype selective ligands
SI0876366T1 (en) *	1996-01-15	2001-12-31	Janssen Pharmaceutica Nv	Angiogenesis inhibiting pyridazinamines
US5929281A (en)	1996-04-19	1999-07-27	Tosoh Corporation	Process for producing heterocyclic aromatic amine or arylamine
SE9601708D0 (sv)	1996-05-06	1996-05-06	Pharmacia Ab	Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
GB9614236D0 (en) *	1996-07-06	1996-09-04	Zeneca Ltd	Chemical compounds
JP3216566B2 (ja) *	1996-07-15	2001-10-09	東ソー株式会社	複素環式芳香族アミン類の製造方法
AU5343498A (en) *	1997-01-21	1998-08-07	Yoshitomi Pharmaceutical Industries, Ltd.	Thiophene compounds and medicinal use thereof
DE19724980A1 (de) *	1997-06-13	1998-12-17	Basf Ag	3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung
AU8457298A (en) *	1997-08-15	1999-03-08	Pfizer Products Inc.	2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives interacting with the dopamine D4 receptor
CN1145609C (zh) *	1997-10-14	2004-04-14	三菱制药株式会社	哌嗪化合物及其作为医药的用途
SK285198B6 (sk) *	1997-10-27	2006-08-03	Neurosearch A/S	Homopiperazínový derivát, farmaceutická kompozícia obsahujúca tento derivát a jeho použitie
GB9726736D0 (en)	1997-12-18	1998-02-18	Zeneca Ltd	Chemical compounds

1998
- 1998-10-27 SK SK614-2000A patent/SK285198B6/sk not_active IP Right Cessation
- 1998-10-27 IL IL13510898A patent/IL135108A0/xx active IP Right Grant
- 1998-10-27 DE DE69826883T patent/DE69826883T2/de not_active Expired - Lifetime
- 1998-10-27 CZ CZ20001507A patent/CZ299499B6/cs not_active IP Right Cessation
- 1998-10-27 DE DE69842058T patent/DE69842058D1/de not_active Expired - Lifetime
- 1998-10-27 PL PL340224A patent/PL203140B1/pl not_active IP Right Cessation
- 1998-10-27 AT AT98951286T patent/ATE278670T1/de active
- 1998-10-27 EE EEP200000178A patent/EE04588B1/xx not_active IP Right Cessation
- 1998-10-27 DK DK98951286T patent/DK1027336T3/da active
- 1998-10-27 BR BRPI9813279-2A patent/BR9813279B1/pt not_active IP Right Cessation
- 1998-10-27 NZ NZ503520A patent/NZ503520A/xx unknown
- 1998-10-27 JP JP2000517946A patent/JP4570773B2/ja not_active Expired - Fee Related
- 1998-10-27 KR KR1020007004495A patent/KR100607838B1/ko not_active Expired - Fee Related
- 1998-10-27 ES ES98951286T patent/ES2230723T3/es not_active Expired - Lifetime
- 1998-10-27 AT AT04102866T patent/ATE491689T1/de not_active IP Right Cessation
- 1998-10-27 RU RU2000110744/04A patent/RU2205179C2/ru not_active IP Right Cessation
- 1998-10-27 HU HU0100426A patent/HU226859B1/hu not_active IP Right Cessation
- 1998-10-27 CN CN98810601A patent/CN1131211C/zh not_active Expired - Fee Related
- 1998-10-27 CA CA2306093A patent/CA2306093C/en not_active Expired - Fee Related
- 1998-10-27 EP EP98951286A patent/EP1027336B1/de not_active Expired - Lifetime
- 1998-10-27 WO PCT/DK1998/000465 patent/WO1999021834A1/en not_active Ceased
- 1998-10-27 PT PT98951286T patent/PT1027336E/pt unknown
- 1998-10-27 EP EP04102866A patent/EP1491532B1/de not_active Expired - Lifetime
- 1998-10-27 AU AU97368/98A patent/AU744539B2/en not_active Ceased
- 1998-10-27 TR TR2000/01171T patent/TR200001171T2/xx unknown
2000
- 2000-03-16 IL IL135108A patent/IL135108A/en not_active IP Right Cessation
- 2000-03-17 US US09/528,176 patent/US6825189B1/en not_active Expired - Fee Related
- 2000-03-28 IS IS5420A patent/IS5420A/is unknown
- 2000-04-26 NO NO20002132A patent/NO317094B1/no not_active IP Right Cessation
2003
- 2003-10-03 US US10/677,240 patent/US6897219B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DK1027336T3 (da)	2005-01-24
US20040072823A1 (en)	2004-04-15
SK6142000A3 (en)	2000-09-12
NZ503520A (en)	2002-08-28
EP1027336A1 (de)	2000-08-16
SK285198B6 (sk)	2006-08-03
PL203140B1 (pl)	2009-08-31
EE200000178A (et)	2001-04-16
WO1999021834A1 (en)	1999-05-06
BR9813279B1 (pt)	2010-11-16
DE69842058D1 (de)	2011-01-27
NO317094B1 (no)	2004-08-09
HK1031378A1 (en)	2001-06-15
PL340224A1 (en)	2001-01-15
CA2306093A1 (en)	1999-05-06
EE04588B1 (et)	2006-02-15
DE69826883D1 (de)	2004-11-11
CN1277604A (zh)	2000-12-20
KR100607838B1 (ko)	2006-08-04
NO20002132L (no)	2000-04-26
CA2306093C (en)	2011-01-04
TR200001171T2 (tr)	2000-10-23
PT1027336E (pt)	2005-01-31
HUP0100426A3 (en)	2002-03-28
CN1131211C (zh)	2003-12-17
JP4570773B2 (ja)	2010-10-27
KR20010031461A (ko)	2001-04-16
CZ20001507A3 (cs)	2000-08-16
IS5420A (is)	2000-03-28
EP1491532A1 (de)	2004-12-29
NO20002132D0 (no)	2000-04-26
US6825189B1 (en)	2004-11-30
ATE278670T1 (de)	2004-10-15
EP1027336B1 (de)	2004-10-06
AU9736898A (en)	1999-05-17
BR9813279A (pt)	2000-08-22
HUP0100426A2 (hu)	2002-02-28
EP1491532B1 (de)	2010-12-15
IL135108A (en)	2006-12-31
RU2205179C2 (ru)	2003-05-27
IL135108A0 (en)	2001-05-20
JP2001521025A (ja)	2001-11-06
HU226859B1 (en)	2009-12-28
US6897219B2 (en)	2005-05-24
CZ299499B6 (cs)	2008-08-13
ES2230723T3 (es)	2005-05-01
AU744539B2 (en)	2002-02-28
DE69826883T2 (de)	2005-02-03

Publication	Publication Date	Title
ATE278670T1 (de)	2004-10-15	Heteroaryl diazacycloalkane als cholinergische ligande für nikotin-acetylcholin-rezeptoren
ATE390404T1 (de)	2008-04-15	Aminderivate, ihre herstellung und verwendung als inhibitoren der produktion von amyloid-beta
TR199801594A2 (xx)	1999-03-22	CCR-3 resept�r antagonistleri.
ZA984637B (en)	1998-12-21	Spiro-quinuclidine derivatives their preparation and use
ATE527247T1 (de)	2011-10-15	Benzokondensierte 5gliedrige heterocyclische verbindungen, verfahren zu deren herstellung und deren verwendung
YU53100A (sh)	2003-04-30	Derivati 2-ariletil-(piperidin-4-ilmetil)amina kao antagonisti muskarinskih receptora
ATE220399T1 (de)	2002-07-15	Neue naphthamid-derivate und ihre therapeutische verwendung als d3-rezeptor agonisten
BR0112043A (pt)	2003-10-28	Ftalidas substituìdas, processo para sua preparação e composições farmacêuticas contendo-as
DK1034174T3 (da)	2003-09-22	Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer
IL65802A0 (en)	1982-08-31	1-(3-halo-2-pyridinyl)piperazines and salts thereof,their preparation and pharmaceutical compositions containing them
DE69817557D1 (de)	2003-10-02	Piperidine derivate als inhibitoren der neurotransmitter-wiederaufbaunahme
ATE311384T1 (de)	2005-12-15	Eine amidgruppe tragende schwefelhaltige verbindungen, verfahren zu ihrer herstellung, deren verwendung in medikamenten und sie enthaltende pharmazeutische zubereitungen
FI963440A0 (fi)	1996-09-03	Uudet aminohappojohdannaiset, näiden valmistusmenetelmä ja näitä yhdisteitä sisältävät farmaseuttiset seokset
KR880001587A (ko)	1988-04-25	[2-디메틸아미노에틸][2-[2-(메틸티오)페닐](페닐메틸)아미노]-2-옥소에틸]카바메이트 또는 요소, 그의 제법 및 치료에의 응용
DE69637941D1 (de)	2009-07-09	Modifizierte hämoglobinähnliche verbindungen und verfahren zu deren reinigung
DK0984943T3 (da)	2003-03-17	Azacycloalkan og -alkenderivater, deres fremstilling og anvendelse
PL321545A1 (en)	1997-12-08	Substituted phenyl compounds and method of applying them as endoteline antagonists
Aiglstorfer et al.	1998	NPY Y1 antagonists: structure–activity relationships of arginine derivatives and hybrid compounds with arpromidine-like partial structures
FR2777780B1 (fr)	2001-05-04	Derives d'(alpha-aminophosphino) peptides, leur procede de preparation et les compositions qui les contiennent
PT880496E (pt)	2002-10-31	Compostos bifenilos e sua utilizacao como agentes estrogenicos
TR200001976T2 (tr)	2000-11-21	İzopropil-Metil [2-(3-n-propoksifenoksi)etil] amin'in hazırlanmasına yönelik usul
ATE245155T1 (de)	2003-08-15	N-substituierte 1-(butyrolacton)-isochinoline zur behandlung von nervenstörungen
FI932206A7 (fi)	1993-05-14	Uusia heterosyklisiä yhdisteitä ekskitatoristen aminohapporeseptorien antagonisteina, menetelmä niiden valmistamiseksi ja niiden käyttö
TH52364A (th)	2002-08-02	ปรปักษ์ของตัวรับเบนซอกซาซิโนนโดพามีน d4
WO2001029017A3 (fr)	2001-12-13	3-AMINO-2,2-DI-C-ALKYL-1,4-BUTYROLACTONES ET 1,4-THIOBUTYROLACTONES N-SUBSTITUEES UTILES COMME STIMULANT DE L'ACTIVITE DE L'ACIDE η-AMINOBUTYRIQUE ET DANS LE TRAITEMENT DES TROUBLES NERVEUX ET LEUR PROCEDE DE PREPARATION

Legal Events

Date	Code	Title	Description
2011-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties